Alissa Greenbaum1, David R Martin2, Thèrése Bocklage3, Ji-Hyun Lee4, Scott A Ness5, Ashwani Rajput6. 1. Division of Surgical Oncology, Department of Surgery, University of New Mexico, Albuquerque, NM. 2. Department of Pathology, University of New Mexico, Albuquerque, NM. 3. Department of Pathology and Laboratory Medicine, University of Kentucky Albert B. Chandler Hospital, Lexington, KY. 4. Department of Biostatistics, College of Public Health and Health Professions College of Medicine, University of Florida, Gainesville, FL. 5. Division of Molecular Medicine, Department of Internal Medicine, University of New Mexico, Albuquerque, NM; University of New Mexico Comprehensive Cancer Center, Albuquerque, NM. 6. Division of Surgical Oncology, Department of Surgery, University of New Mexico, Albuquerque, NM; University of New Mexico Comprehensive Cancer Center, Albuquerque, NM. Electronic address: arajput@salud.unm.edu.
Abstract
BACKGROUND: Neoadjuvant chemoradiotherapy (nCRT) is the standard of care for locally advanced adenocarcinoma of the rectum, but it is currently unknown which patients have disease that will respond. This study tested the correlation between response to nCRT and intratumoral heterogeneity using next-generation sequencing assays. PATIENTS AND METHODS: DNA was extracted from formalin-fixed, paraffin-embedded biopsy samples from a cohort of patients with locally advanced rectal adenocarcinoma (T3/4 or N1/2 disease) who received nCRT. High read-depth sequencing of > 400 cancer-relevant genes was performed. Tumor mutations and variant allele frequencies were used to calculate mutant-allele tumor heterogeneity (MATH) scores as measures of intratumoral heterogeneity. Response to nCRT was pathologically scored after surgical resection. RESULTS: Biopsy samples from 21 patient tumors were analyzed. Eight patients had disease noted to have complete response, 2 moderate, 4 minimal, and 7 poor. Higher MATH scores correlated with poorer response to treatment, demonstrating significantly increased tumor heterogeneity compared to complete response (P = .039). CONCLUSION: The application of MATH scores as a measure of tumor heterogeneity may provide a useful biomarker for treatment response in locally advanced rectal cancer.
BACKGROUND: Neoadjuvant chemoradiotherapy (nCRT) is the standard of care for locally advanced adenocarcinoma of the rectum, but it is currently unknown which patients have disease that will respond. This study tested the correlation between response to nCRT and intratumoral heterogeneity using next-generation sequencing assays. PATIENTS AND METHODS: DNA was extracted from formalin-fixed, paraffin-embedded biopsy samples from a cohort of patients with locally advanced rectal adenocarcinoma (T3/4 or N1/2 disease) who received nCRT. High read-depth sequencing of > 400 cancer-relevant genes was performed. Tumor mutations and variant allele frequencies were used to calculate mutant-allele tumor heterogeneity (MATH) scores as measures of intratumoral heterogeneity. Response to nCRT was pathologically scored after surgical resection. RESULTS: Biopsy samples from 21 patienttumors were analyzed. Eight patients had disease noted to have complete response, 2 moderate, 4 minimal, and 7 poor. Higher MATH scores correlated with poorer response to treatment, demonstrating significantly increased tumor heterogeneity compared to complete response (P = .039). CONCLUSION: The application of MATH scores as a measure of tumor heterogeneity may provide a useful biomarker for treatment response in locally advanced rectal cancer.
Authors: Rolf Sauer; Heinz Becker; Werner Hohenberger; Claus Rödel; Christian Wittekind; Rainer Fietkau; Peter Martus; Jörg Tschmelitsch; Eva Hager; Clemens F Hess; Johann-H Karstens; Torsten Liersch; Heinz Schmidberger; Rudolf Raab Journal: N Engl J Med Date: 2004-10-21 Impact factor: 91.245
Authors: Raymond H Mak; Ellen P McCarthy; Prajnan Das; Theodore S Hong; Harvey J Mamon; Karen E Hoffman Journal: Int J Radiat Oncol Biol Phys Date: 2010-10-18 Impact factor: 7.038
Authors: Monique Maas; Patty J Nelemans; Vincenzo Valentini; Prajnan Das; Claus Rödel; Li-Jen Kuo; Felipe A Calvo; Julio García-Aguilar; Rob Glynne-Jones; Karin Haustermans; Mohammed Mohiuddin; Salvatore Pucciarelli; William Small; Javier Suárez; George Theodoropoulos; Sebastiano Biondo; Regina G H Beets-Tan; Geerard L Beets Journal: Lancet Oncol Date: 2010-08-06 Impact factor: 41.316
Authors: Mariangela Russo; Giulia Siravegna; Lawrence S Blaszkowsky; Giorgio Corti; Giovanni Crisafulli; Leanne G Ahronian; Benedetta Mussolin; Eunice L Kwak; Michela Buscarino; Luca Lazzari; Emanuele Valtorta; Mauro Truini; Nicholas A Jessop; Hayley E Robinson; Theodore S Hong; Mari Mino-Kenudson; Federica Di Nicolantonio; Ashraf Thabet; Andrea Sartore-Bianchi; Salvatore Siena; A John Iafrate; Alberto Bardelli; Ryan B Corcoran Journal: Cancer Discov Date: 2015-12-07 Impact factor: 39.397
Authors: Edmund A Mroz; Aaron D Tward; Curtis R Pickering; Jeffrey N Myers; Robert L Ferris; James W Rocco Journal: Cancer Date: 2013-05-20 Impact factor: 6.860
Authors: Niels W Schurink; Simon R van Kranen; Maaike Berbee; Wouter van Elmpt; Frans C H Bakers; Sander Roberti; Joost J M van Griethuysen; Lisa A Min; Max J Lahaye; Monique Maas; Geerard L Beets; Regina G H Beets-Tan; Doenja M J Lambregts Journal: Eur Radiol Date: 2021-02-10 Impact factor: 5.315
Authors: Niels W Schurink; Lisa A Min; Maaike Berbee; Wouter van Elmpt; Joost J M van Griethuysen; Frans C H Bakers; Sander Roberti; Simon R van Kranen; Max J Lahaye; Monique Maas; Geerard L Beets; Regina G H Beets-Tan; Doenja M J Lambregts Journal: Eur Radiol Date: 2020-02-07 Impact factor: 5.315
Authors: Natally Horvat; Harini Veeraraghavan; Caio S R Nahas; David D B Bates; Felipe R Ferreira; Junting Zheng; Marinela Capanu; James L Fuqua; Maria Clara Fernandes; Ramon E Sosa; Vetri Sudar Jayaprakasam; Giovanni G Cerri; Sergio C Nahas; Iva Petkovska Journal: Abdom Radiol (NY) Date: 2022-06-16
Authors: Stephanie J Yaung; Christine Ju; Sandeep Gattam; Alan Nicholas; Nicolas Sommer; Johanna C Bendell; Herbert I Hurwitz; John J Lee; Fergal Casey; Richard Price; John F Palma Journal: Cancers (Basel) Date: 2022-04-29 Impact factor: 6.575
Authors: Wei Zhang; Hongkun Yin; Zixing Huang; Jian Zhao; Haoyu Zheng; Du He; Mou Li; Weixiong Tan; Song Tian; Bin Song Journal: Cancer Med Date: 2021-05-08 Impact factor: 4.452
Authors: Floris A Vuijk; Carlijn van de Water; Shannon Lent-van Vliet; Maxime J M van der Valk; Femke Simmer; Cornelis J H van de Velde; Alexander L Vahrmeijer; Iris D Nagtegaal; Denise E Hilling Journal: Cancers (Basel) Date: 2021-05-09 Impact factor: 6.639